BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Cardiol. Nov 26, 2026; 18(11): 124181
Published online Nov 26, 2026. doi: 10.4330/wjc.124181
Figure 1
Figure 1 Efficacy of Xin-II in treating chronic heart failure. A: Flowchart of the animal experiment; B: Graph showing body weight statistics for each group; C: Mortality statistics for each group; D: Cardiac function testing in animals (n = 3); E: Statistical results of echocardiography (n = 3). Data are presented as mean ± SEM. Statistical significance was determined by one-way analysis of variance followed by Tukey’s multiple comparisons test. aP < 0.05 (control vs model group); bP < 0.05 (model vs Xin-II group). NS: Not significant; CK: Creatine kinase; BNP: Brain natriuretic peptide; EF: Ejection fraction; FS: Fractional shortening; LVIDd: Left ventricular internal diastolic dimension; LVIDs: Left ventricular internal dimension in systole.


Write to the Help Desk